Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses
Willemijn F. Rijnink(Icahn School of Medicine at Mount Sinai), Florian Krammer(Icahn School of Medicine at Mount Sinai)
Cited by 16
Related Papers
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
|New England Journal of Medicine|2021|803
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
|Immunity|2021|713
Advances in the development of influenza virus vaccines
|Nature Reviews Drug Discovery|2015|597